Patent · US Active

Methods for determining drug efficacy using cereblon-associated proteins

US9857359B2 · kind B2 · utility

7Cited by
58References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2013
Grant dateJan 2, 2018
Priority date—
Expiry dateJun 28, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Use of cereblon-associated proteins as biomarkers for clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.